Please sign in to follow a disease.
Could better pregnancy nutrition boost baby brainpower? new study follows 463 children in ethiopia
NCT ID NCT06296238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows children born to mothers who took part in a larger trial in rural Ethiopia. Some mothers received extra nutrition (protein, iron, iodine) or treatment for infections during pregnancy. Researchers will measure brain activity, attention, and growth in these children up to age 2 to see if the pregnancy interventions helped their brain development.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If links are found, this could point toward simple, low-cost ways to improve early brain development in low-resource settings.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. Results may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
463 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Jul 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The participants of this study will be recruited from 6 rural health centers (serving a \~25,000 population) involved in ENAT study in West Gojjam and South Gondar zones, Amhara, Ethiopia (Lee et al., 2022). In this infant follow-up study, up to 500 selected infants from the parent ENAT study will be followed for 24 months for general health, growth, and development. A subset of these infants (up to 480) whose mothers provided biospecimens or whose mothers had mid-upper arm circumference (MUAC) of \<23 cm in the parent study will be recruited for an advanced neurodevelopmental assessment study.
- Ages
-
9 to 27 months
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Mothers who have participated in ENAT study who consent to participate in the infant follow up study * Intention to stay in the study catchment area * Healthy infants without severe clinical signs or symptoms including headache, vomiting, or dizziness Exclusion criteria: * Major congenital anomalies * Infants with severe morbidity or developmental disorder * Neonatal encephalopathy * Plan to move out of study catchment area
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prenatal exposure delayed effects are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Health Centers in West Gojjam and South Gondar zones
Bahir Dar, Amhara, Ethiopia